
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 21, 2023, titled "Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S".
Filed with NSE ·
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 21, 2023, titled "Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S".
6ix hasn’t read this filing yet.
Dr. Reddy's Laboratories Ltd. on 6ix
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories